Skip to Content


Notice of Intent To Grant an Exclusive License of a U.S. Government-Owned Patent; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


U.S. Army Medical Research and Materiel Command, DOD.


Notice; correction.


The U.S. Army Medical Research and Materiel Command published a document in the Federal Register of October 18, 2001, concerning intent to grant an exclusive license of a U.S. Government-owned patent. Inadvertently, the incorrect information was provided under the summary.

Start Further Info


For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664. Both at telefax (301) 619-5034.


In the Federal Register of Oct 18, 2001, in FR Doc. 01-26191, on page 52898, in the second column, correct the SUMMARY caption to read:

End Further Info


In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license to U.S. patent number 5,607,979 issued March 4, 1997 entitled “Topical Skin Protectants” to DFB Pharmaceuticals, Inc with its principal place of business at 3909 Hulen Street, Fort Worth, Texas 76107.

Start Signature

Luz D. Ortiz,

Army Federal Register Liaison Officer.

End Signature End Preamble

[FR Doc. 01-27627 Filed 11-1-01; 8:45 am]